{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:20:21Z","timestamp":1781011221438,"version":"3.54.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.lfs.2003.07.018","type":"journal-article","created":{"date-parts":[[2003,11,8]],"date-time":"2003-11-08T12:13:10Z","timestamp":1068293590000},"page":"827-834","source":"Crossref","is-referenced-by-count":61,"title":["CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects"],"prefix":"10.1016","volume":"74","author":[{"given":"Yoshihiko","family":"Soga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusanori","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisa","family":"Naruishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Takashiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Gomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lfs.2003.07.018_BIB1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0030-4220(72)90228-9","article-title":"Incidence of dephenylhydantoin gingival hyperplasia","volume":"34","author":"Angelopoulos","year":"1972","journal-title":"Oral Surgery"},{"issue":"7","key":"10.1016\/j.lfs.2003.07.018_BIB2","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/bi00173a017","article-title":"Evidence that CYP2C19 is the major (S)-mephenytoin 4\u2032-hydroxylase in humans","volume":"33","author":"Goldstein","year":"1994","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.lfs.2003.07.018_BIB3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1248\/bpb.19.1103","article-title":"Effect of CYP2C polymorphisms on the phamacokinetics of phenytoin in Japanese patients with epilepsy","volume":"19","author":"Hashimoto","year":"1996","journal-title":"Biology and Pharmacology Bulletins"},{"issue":"6","key":"10.1016\/j.lfs.2003.07.018_BIB4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0009-9236(96)90214-3","article-title":"Genotyping of S-mephenytoin 4\u2032-hydroxylation in an extended Japanese population","volume":"60","author":"Kubota","year":"1996","journal-title":"Clinical and Pharmacological Therapies"},{"issue":"6","key":"10.1016\/j.lfs.2003.07.018_BIB5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/BF00541938","article-title":"Phamacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man","volume":"26","author":"Kupfer","year":"1984","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"12","key":"10.1016\/j.lfs.2003.07.018_BIB6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1528-1157.1998.tb01330.x","article-title":"The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: Studies in stereoselective hydroxylation and population pharmacokinetics","volume":"39","author":"Mamiya","year":"1998","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.lfs.2003.07.018_BIB7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1985.194","article-title":"Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations","volume":"38","author":"Nakamura","year":"1985","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"12","key":"10.1016\/j.lfs.2003.07.018_BIB8","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0002-9440(10)64483-5","article-title":"Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth. A study with cathepsin-L-deficient mice","volume":"161","author":"Nishimura","year":"2002","journal-title":"American Journal of Pathology"},{"issue":"3","key":"10.1016\/j.lfs.2003.07.018_BIB9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0009-9236(97)90031-X","article-title":"Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy","volume":"62","author":"Odani","year":"1997","journal-title":"Clinical and Pharmacological Therapies"},{"issue":"22","key":"10.1016\/j.lfs.2003.07.018_BIB10","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1016\/S0021-9258(17)40694-6","article-title":"The major genetic defect responsible for the polymorphism of S-Mephenytoin metabolism in humans","volume":"269","author":"de Morais","year":"1994","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.lfs.2003.07.018_BIB11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008571-199610000-00007","article-title":"Genetic analysis of the human cytochrome P450 CYP2C9 locus","volume":"6","author":"Stubbins","year":"1996","journal-title":"Phamacogenetics"},{"issue":"4","key":"10.1016\/j.lfs.2003.07.018_BIB12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00008571-199608000-00007","article-title":"The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism","volume":"6","author":"Sullivan-Klose","year":"1996","journal-title":"Pharmacogenetics"},{"issue":"3","key":"10.1016\/j.lfs.2003.07.018_BIB13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/0006-291X(91)91680-B","article-title":"Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P450 2C9","volume":"175","author":"Veronese","year":"1991","journal-title":"Biochemical Biophysical Research Communications"},{"issue":"6","key":"10.1016\/j.lfs.2003.07.018_BIB14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1902\/jop.2000.71.6.955","article-title":"Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts","volume":"71","author":"Yamada","year":"2000","journal-title":"Journal of Periodontology"},{"issue":"2","key":"10.1016\/j.lfs.2003.07.018_BIB15","first-page":"42","article-title":"Serum phenytoin concentration and IgG antibody titer to periodontal bacteria in patients with phenytoin-induced gingival overgrowth","volume":"3","author":"Yamada","year":"2001","journal-title":"Journal of the International Academy of Periodontology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320503009639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320503009639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T18:26:36Z","timestamp":1623522396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320503009639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0024320503009639"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2003.07.018","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}